Nerve growth factor for neuropathic pain

Yang Zhang; Siyin Gong; Li He; Muke Zhou; Jian Guo; Ahmet Hoke; Cairong Zhu

doi:10.1002/14651858.CD012800

Nerve growth factor for neuropathic pain

Yang Zhang, Siyin Gong, Li He, Muke Zhou, Jian Guo, Ahmet Hoke, Cairong Zhu

School of Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the analgesic efficacy and adverse effects of nerve growth factor for chronic neuropathic pain.

Original language	English (US)
Article number	CD012800
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	11
DOIs	https://doi.org/10.1002/14651858.CD012800
State	Published - Nov 4 2017

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD012800

Cite this

@article{276702dcb4754192be2cf9ab5efc0ceb,

title = "Nerve growth factor for neuropathic pain",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the analgesic efficacy and adverse effects of nerve growth factor for chronic neuropathic pain.",

author = "Yang Zhang and Siyin Gong and Li He and Muke Zhou and Jian Guo and Ahmet Hoke and Cairong Zhu",

note = "Publisher Copyright: {\textcopyright} 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2017",

month = nov,

day = "4",

doi = "10.1002/14651858.CD012800",

language = "English (US)",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "11",

}

TY - JOUR

T1 - Nerve growth factor for neuropathic pain

AU - Zhang, Yang

AU - Gong, Siyin

AU - He, Li

AU - Zhou, Muke

AU - Guo, Jian

AU - Hoke, Ahmet

AU - Zhu, Cairong

PY - 2017/11/4

Y1 - 2017/11/4

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the analgesic efficacy and adverse effects of nerve growth factor for chronic neuropathic pain.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the analgesic efficacy and adverse effects of nerve growth factor for chronic neuropathic pain.

UR - http://www.scopus.com/inward/record.url?scp=85032749709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032749709&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012800

DO - 10.1002/14651858.CD012800

M3 - Article

AN - SCOPUS:85032749709

SN - 1465-1858

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 11

M1 - CD012800

ER -

Nerve growth factor for neuropathic pain

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this